期刊文献+
共找到12,893篇文章
< 1 2 250 >
每页显示 20 50 100
Brain endothelial cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway in aging and neurodegeneration
1
作者 Bryan Sun Lulin Li Jian Luo 《Neural Regeneration Research》 SCIE CAS 2025年第7期2005-2007,共3页
The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial ce... The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial cells,emerging research suggests that cGAS-STING signaling may play a critical role in cerebral vasculature,particularly in brain endothelial cells.Therefore,studying the role 7of inflammation caused by the cGAS-STING pathway in brain endothelial cells could provide a more comprehensive understanding of neuroinflammatory disease and new avenues for therapeutic interventions.Here,we review the multifaceted role of global cGAS-STING signaling in various neurological and neuroinflammatory diseases and the potential contribution of cGAS-STING in brain endothelial cells. 展开更多
关键词 STIMULATOR interferon inflammation
下载PDF
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease
2
作者 Shengyang Zhou Ting Li +8 位作者 Wei Zhang Jian Wu Hui Hong Wei Quan Xinyu Qiao Chun Cui Chenmeng Qiao Weijiang Zhao Yanqin Shen 《Neural Regeneration Research》 SCIE CAS 2025年第8期2361-2372,共12页
Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report... Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease. 展开更多
关键词 cyclic guanosine monophosphate adenosine monophosphate synthase H151 interferon regulatory factor 7 M1 phenotype neurodegenerative disease NEUROINFLAMMATION Parkinson’s disease RU521 STING type I interferon
下载PDF
Ropeginterferonα-2b治疗骨髓增殖性肿瘤的研究进展
3
作者 屠玲榕 黄健 《中国实验血液学杂志》 北大核心 2025年第1期306-310,共5页
Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚... Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚乙二醇干扰素α和羟基脲相比,其药物不良反应发生率和严重程度较低,且给药间隔时间更长,部分低危真性红细胞增多症和骨髓纤维化患者也能从中获益。本文就Ropeginterferonα-2b在骨髓增殖性肿瘤中的最新研究进展作一综述。 展开更多
关键词 骨髓增殖性肿瘤 Ropeginterferonα-2b Α干扰素 治疗
下载PDF
Bidirectional regulation of the cyclic guanosine monophosphateadenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
4
作者 Ai-Yu Nie Zhong-Hui Xiao +4 位作者 Jia-Li Deng Na Li Li-Yuan Hao Sheng-Hao Li Xiao-Yu Hu 《World Journal of Gastrointestinal Oncology》 2025年第2期246-261,共16页
BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS... BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)activates the stimulator of interferon gene(STING)signaling pathway as a crucial immune response pathway in the cytoplasm,which detects cytoplasmic DNA to regulate innate and adaptive immune responses.As a potential therapeutic target,cGASSTING pathway markedly inhibits tumor cell proliferation and metastasis,with its activation being particularly relevant in HCC.However,prolonged pathway activation may lead to an immunosuppressive tumor microenvironment,which fostering the invasion or metastasis of liver tumor cells.AIM To investigate the dual-regulation mechanism of cGAS-STING in HCC.METHODS This review was conducted according to the PRISMA guidelines.The study conducted a comprehensive search for articles related to HCC on PubMed and Web of Science databases.Through rigorous screening and meticulous analysis of the retrieved literature,the research aimed to summarize and elucidate the impact of the cGAS-STING pathway on HCC tumors.RESULTS All authors collaboratively selected studies for inclusion,extracted data,and the initial search of online databases yielded 1445 studies.After removing duplicates,remaining 964 records were screened.Ultimately,55 articles met the inclusion criteria and were included in this review.CONCLUSION Acute inflammation can have a few inhibitory effects on cancer,while chronic inflammation generally promotes its progression.Extended cGAS-STING pathway activation will result in a suppressive tumor microenvironment. 展开更多
关键词 Hepatocellular carcinoma Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene interferon genes The metastasis of a tumor IMMUNOLOGY
下载PDF
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis
5
作者 Hongzhen Chen Xuekun Fu +15 位作者 Xiaohao Wu Junyi Zhao Fang Qiu Zhenghong Wang Zhuqian Wang Xinxin Chen Duoli Xie Jie Huang Junyu Fan Xu Yang Yi Song Jie Li Dongyi He Guozhi Xiao Aiping Lu Chao Liang 《Bone Research》 SCIE CAS CSCD 2024年第2期421-437,共17页
Rheumatoid arthritis(RA)is an autoimmune disease.Early studies hold an opinion that gut microbiota is environmentally acquired and associated with RA susceptibility.However,accumulating evidence demonstrates that gene... Rheumatoid arthritis(RA)is an autoimmune disease.Early studies hold an opinion that gut microbiota is environmentally acquired and associated with RA susceptibility.However,accumulating evidence demonstrates that genetics also shape the gut microbiota.It is known that some strains of inbred laboratory mice are highly susceptible to collagen-induced arthritis(CIA),while the others are resistant to CIA.Here,we show that transplantation of fecal microbiota of CIA-resistant C57BL/6J mice to CIA-susceptible DBA/1J mice confer CIA resistance in DBA/1J mice.C57BL/6J mice and healthy human individuals have enriched B.fragilis than DBA/1J mice and RA patients.Transplantation of B.fragilis prevents CIA in DBA/1J mice.We identify that B.fragilis mainly produces propionate and C57BL/6J mice and healthy human individuals have higher level of propionate.Fibroblast-like synoviocytes(FLSs)in RA are activated to undergo tumor-like transformation.Propionate disrupts HDAC3-FOXK1 interaction to increase acetylation of FOXK1,resulting in reduced FOXK1 stability,blocked interferon signaling and deactivation of RA-FLSs.We treat CIA mice with propionate and show that propionate attenuates CIA.Moreover,a combination of propionate with anti-TNF etanercept synergistically relieves CIA.These results suggest that B.fragilis or propionate could be an alternative or complementary approach to the current therapies. 展开更多
关键词 HDAC3 cytes interferon
下载PDF
Expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients:A retrospective study
6
作者 Elham Jafari Maskouni Samaneh Abbasi +4 位作者 Elham Mousavi Zahra Najafimemar Ali Mohammad Arabzadeh Mehrdad Farrokhnia Saeedeh Ebrahimi 《Journal of Acute Disease》 2024年第3期111-115,共5页
Objective:To explore expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients.Methods:In this study,changes in the expression of four interferon... Objective:To explore expression level of interferon-stimulated genes PKR,OAS1,MX1,and ISG15 in peripheral blood mononuclear cells of COVID-19 patients.Methods:In this study,changes in the expression of four interferon-stimulated genes(ISGs),including PKR,OAS1,MX1,and ISG15,in peripheral blood mononuclear cells of 45 COVID-19 patients with different severities were evaluated by real-time PCR method.Results:OAS1,MX1,PKR,and ISG15 were differently expressed in COVID-19 patients with different severity.The results showed that the expression of OAS1,MX1,PKR,and ISG15 genes was significantly(P=0.001)lower in severe patients.Conclusions:Weak and defective IFN response and subsequent disruption of ISGs may be associated with COVID-19 severity. 展开更多
关键词 COVID-19 SARS-CoV-2 interferon ISGs Severe COVID-19 Risk factors interferon signaling
下载PDF
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
7
作者 YANG Liu WANG Shi Yu +13 位作者 JIANG Ting Ting DENG Wen CHANG Min WU Shu Ling CAO Wei Hua LU Yao SHEN Ge LIU Ru Yu GAO Yuan Jiao XU Meng Jiao HU Lei Ping ZHANG Lu XIE Yao LI Ming Hui 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2024年第3期303-314,共12页
Objective This study aimed to evaluate whether the onset of the plateau phase of slow hepatitis B surface antigen decline in patients with chronic hepatitis B treated with intermittent interferon therapy is related to... Objective This study aimed to evaluate whether the onset of the plateau phase of slow hepatitis B surface antigen decline in patients with chronic hepatitis B treated with intermittent interferon therapy is related to the frequency of dendritic cell subsets and expression of the costimulatory molecules CD40,CD80,CD83,and CD86.Method This was a cross-sectional study in which patients were divided into a natural history group(namely NH group),a long-term oral nucleoside analogs treatment group(namely NA group),and a plateau-arriving group(namely P group).The percentage of plasmacytoid dendritic cell and myeloid dendritic cell subsets in peripheral blood lymphocytes and monocytes and the mean fluorescence intensity of their surface costimulatory molecules were detected using a flow cytometer.Results In total,143 patients were enrolled(NH group,n=49;NA group,n=47;P group,n=47).The results demonstrated that CD141/CD1c double negative myeloid dendritic cell(DNmDC)/lymphocytes and monocytes(%)in P group(0.041[0.024,0.069])was significantly lower than that in NH group(0.270[0.135,0.407])and NA group(0.273[0.150,0.443]),and CD86 mean fluorescence intensity of DNmDCs in P group(1832.0[1484.0,2793.0])was significantly lower than that in NH group(4316.0[2958.0,5169.0])and NA group(3299.0[2534.0,4371.0]),Adjusted P all<0.001.Conclusion Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B. 展开更多
关键词 CHB Dendritic Cells Intermittent interferon Therapy Plateau Phase
下载PDF
Evaluation of Interferon-Gamma Release Assay Testing and Tuberculin Skin Test for Early Diagnosis of Tuberculosis in Children and Adolescents
8
作者 Yelda Sorguç Miray Çelebi Yılmaz +4 位作者 Yüce Ayhan Yakup Yaman Şener Tulumoğlu Aybüke Akaslan Kara İlker Devrim 《Open Journal of Pediatrics》 2024年第3期558-567,共10页
Background: This study aimed to evaluate the diagnostic value of interferon-γ release assay (IGRA), a sensitive microbiological diagnostic method, in children and adolescents with suspected tuberculosis in a country ... Background: This study aimed to evaluate the diagnostic value of interferon-γ release assay (IGRA), a sensitive microbiological diagnostic method, in children and adolescents with suspected tuberculosis in a country with a high burden of tuberculosis. Method: This study included 581 children and adolescents aged 4 - 19 years who were suspected of having tuberculosis, were latently infected with Mycobacterium tuberculosis, and had received at least one dose of BCG vaccine between April 17, 2019, and February 24, 2021. The study evaluated the TST results of 106 patients who had a positive Quantiferon test and were suspected of having tuberculosis. Results: The study included 581 patients aged between 4 and 19 years. Of these, 106 patients tested positive for the Quantiferon test, while 19 were indeterminate and 456 were negative. The Quantiferon test positivity rate was 18.24%. Among the 106 QFT-Plus-positive cases, 23 patients also tested positive for TST. The difference in distribution was found to be statistically significant. Conclusion: The QFT-Plus test is considered an alternative to TST and other microbiological diagnostic methods for early tuberculosis diagnosis, particularly in children and adolescents. 展开更多
关键词 interferon Gamma Release Assay CHILDREN Tuberculin Test CHILDREN Latent Tuberculosis
下载PDF
Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications
9
作者 Ming-Wei Fan Jin-Lan Tian +5 位作者 Tan Chen Can Zhang Xin-Ru Liu Zi-Jian Zhao Shu-Hui Zhang Yan Chen 《World Journal of Diabetes》 SCIE 2024年第10期2041-2057,共17页
Diabetes mellitus(DM)is one of the major causes of mortality worldwide,with inflammation being an important factor in its onset and development.This review summarizes the specific mechanisms of the cyclic guanosine mo... Diabetes mellitus(DM)is one of the major causes of mortality worldwide,with inflammation being an important factor in its onset and development.This review summarizes the specific mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)pathway in mediating inflammatory responses.Furthermore,it compre-hensively presents related research progress and the subsequent involvement of this pathway in the pathogenesis of early-stage DM,diabetic gastroenteropathy,diabetic cardiomyopathy,non-alcoholic fatty liver disease,and other complic-ations.Additionally,the role of cGAS-STING in autonomic dysfunction and intes-tinal dysregulation,which can lead to digestive complications,has been discuss-ed.Altogether,this study provides a comprehensive analysis of the research advances regarding the cGAS-STING pathway-targeted therapeutic agents and the prospects for their application in the precision treatment of DM. 展开更多
关键词 Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes Diabetes mellitus Inflammation Glycolipid metabolism Diabetes gastroenteropathy Nonalcoholic fatty liver disease Diabetes cardiovascular disease Diabetes nephropathy
下载PDF
蓝芩口服液联合重组人干扰素α-2b喷雾剂治疗疱疹性咽峡炎的效果
10
作者 张磊 汤昱 +1 位作者 徐沙沙 陈守航 《河南医学研究》 2025年第1期52-55,共4页
目的探讨蓝芩口服液联合重组人干扰素α-2b治疗儿童疱疹性咽峡炎心脾积热证的有效性及安全性。方法采用随机对照方法将2021年1月至2022年12月于河南省儿童医院治疗并符合标准的120例患儿分为对照组和治疗组,各60例。对照组接受重组人干... 目的探讨蓝芩口服液联合重组人干扰素α-2b治疗儿童疱疹性咽峡炎心脾积热证的有效性及安全性。方法采用随机对照方法将2021年1月至2022年12月于河南省儿童医院治疗并符合标准的120例患儿分为对照组和治疗组,各60例。对照组接受重组人干扰素α-2b喷雾剂(假单胞菌),治疗组在对照组的基础上接受蓝芩口服液口服,疗程5 d。以两组患儿临床疗效、退热时间、咽痛消失时间、疱疹消失时间及中医证候总积分进行有效性评价,以药物不良反应进行安全性评价。结果与对照组相比,治疗组更能有效缩短疱疹性咽峡炎患儿退热时间、咽痛消失时间、疱疹消失时间及改善中医证候,治疗过程中未出现严重不良反应。结论蓝芩口服液联合重组人干扰素α-2b可提高疱疹性咽峡炎患儿的临床疗效,优于单用重组人干扰素α-2b,且安全性好,值得采用。 展开更多
关键词 疱疹性咽峡炎 蓝芩口服液 重组人干扰素 疗效
下载PDF
参莲消积方治疗慢性萎缩性胃炎气虚瘀热证临床研究
11
作者 张娜 黄玉珍 +1 位作者 苏坤涵 刘万里 《陕西中医》 2025年第2期197-200,共4页
目的:分析参莲消积方治疗慢性萎缩性胃炎(CAG)气虚瘀热证的治疗效果。方法:采用随机数字表法将60例CAG气虚瘀热证患者分为观察组和对照组各30例,分别给予参莲消积方、胃复春片口服治疗,疗程皆为24周。对比分析两组治疗效果、两组前后中... 目的:分析参莲消积方治疗慢性萎缩性胃炎(CAG)气虚瘀热证的治疗效果。方法:采用随机数字表法将60例CAG气虚瘀热证患者分为观察组和对照组各30例,分别给予参莲消积方、胃复春片口服治疗,疗程皆为24周。对比分析两组治疗效果、两组前后中医证候积分、胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)、γ-干扰素(IFN-γ)水平的变化情况,并记录不良反应。结果:观察组治疗总有效率为86.67%(26/30),显著高于对照组的63.33%(19/30,P<0.05),两组治疗后中医证候积分均显著低于治疗前(P<0.05),PGⅠ、PGⅡ、IFN-γ水平均显著改善(P<0.05),观察组治疗后各项指标改善情况均优于对照组(P<0.05),两组均未见不良反应。结论:参莲消积方治疗CAG气虚瘀热证的临床疗效显著,可有效缓解症状,改善PGⅠ、PGⅡ、IFN-γ水平。 展开更多
关键词 慢性萎缩性胃炎 气虚瘀热证 参莲消积方 胃蛋白酶原 Γ干扰素
下载PDF
实验性自身免疫性葡萄膜炎小鼠发病中Tim-3的表达及其作用
12
作者 吴雄飞 张秋瑾 +3 位作者 郑柳 杨彬彬 李金清 丁芝祥 《眼科新进展》 CAS 北大核心 2025年第1期10-14,共5页
目的探讨T细胞免疫球蛋白黏蛋白分子-3(Tim-3)在实验性自身免疫性葡萄膜炎(EAU)发病中的表达和作用。方法选取4~5周龄雄性C57BL/6J小鼠共12只;采用随机数字表法将12只小鼠分为对照组(3只)和实验组(9只)。对照组(造模时间节点为造模后0 d... 目的探讨T细胞免疫球蛋白黏蛋白分子-3(Tim-3)在实验性自身免疫性葡萄膜炎(EAU)发病中的表达和作用。方法选取4~5周龄雄性C57BL/6J小鼠共12只;采用随机数字表法将12只小鼠分为对照组(3只)和实验组(9只)。对照组(造模时间节点为造模后0 d)不做任何处理,实验组小鼠诱导建立EAU模型(按造模时间节点分为造模后7 d、14 d、21 d三个小组,每组3只小鼠)。将光感受器间维生素A类结合蛋白651-670和完全弗氏佐剂充分混合乳化后,在实验组小鼠的双侧大腿、尾根部及颈后部皮下注射配制好的免疫乳剂(每只注射200μL免疫乳剂,含500μg光感受器间维生素A类结合蛋白651-670),随后实验组每只小鼠腹腔注射1μg百日咳毒素。通过裂隙灯显微镜观察各组小鼠眼前节及眼底表现并采集图像。根据炎症程度采用Caspi分级标准对小鼠行临床评分及组织病理学评分。ELISA法检测小鼠血清中IFN-γ、IL-17的表达;实时荧光定量PCR法检测小鼠脾脏及眼球组织中Tim-3 mRNA的表达;Western blot法检测Tim-3蛋白的表达;免疫组织化学法检测脾脏组织Tim-3蛋白的表达。采用Graphpad Prism 9.0统计软件进行数据分析。结果造模后小鼠的眼前节临床评分、眼底临床评分、组织病理学评分均随造模后时间的延长呈升高趋势,各组间的评分差异均有统计学意义(均为P<0.05)。造模后小鼠血清中IFN-γ、IL-17的表达量均随造模后时间的延长呈升高趋势,且各组间的差异均有统计学意义(均为P<0.05)。造模后小鼠脾脏与眼球组织中Tim-3 mRNA的相对表达量均随造模后时间的延长呈下降趋势,且各组间的差异均有统计学意义(均为P<0.05)。小鼠眼球和脾脏组织中Tim-3蛋白的表达情况和mRNA相同。结论Tim-3在EAU发病进程中的表达随着炎症的加重呈下调趋势,Tim-3在葡萄膜炎发病进程中可能发挥着负性免疫调控作用。 展开更多
关键词 实验性自身免疫性葡萄膜炎 自身免疫性疾病 TIM-3 干扰素-Γ 白细胞介素
下载PDF
Assessment of natural and interleukin-2-induced production of interferon-gamma in patients with liver diseases
13
作者 陈士葆 缪晓辉 +1 位作者 杜平 吴清璇 《World Journal of Gastroenterology》 SCIE CAS CSCD 1996年第3期173-175,共3页
AIMS To clarify whether the lower interferon gamma (IFNγ) production by lymphocytes in patients with liver diseases is due to defects of lymphocytes themselves or of other cofactors such as interleukin-2(IL-2). METHO... AIMS To clarify whether the lower interferon gamma (IFNγ) production by lymphocytes in patients with liver diseases is due to defects of lymphocytes themselves or of other cofactors such as interleukin-2(IL-2). METHODS Peripheral blood mononuclear cells (PBMCs) from patients with various liver diseases were cultured with or without PHA and IL-2. The cells were harvested and counted and the su- pernatants were tested for IFNγ by a sensitive and quantitative ABC-ELISA. RESULTS IFNγ was not round in serum samples from patients as well as normal individuals. However,in supernatants of non-in- duced and induced PBMCs,IFN7 was detected by ABC-ELISA. In non-induced PBMCs (group 1),the content of IFNγ in super- natants from control,CAH,CPH and HCC was 8.72 μg/L, 5.03 μg/L,6.02 μg/L and 4.91 μg/L respectively. The pro- duction of IFNγ in liver disease was significantly decreased,com- pared to control. In group 2 in which PBMCs were stimulated with PHA,the content of IFNγ was 22.71,17.12,14.54 and 17.63 μg/L respectively. In group 3 in which PBMCs were in- duced by IL-2,the amount of IFN7 in supernatant from control (60.67 μg/L) was much larger than those from CAH (21.70 μg/ L),CPH (24.00 μg/L) and HCC (19.15 μg/L) (P<0.01). Comparing the amount of IFNγ in group 3 (IL-2-induced) with that in group 1 (non-induced),we found that IFNγ production was en- hanced by nearly 4 folds in liver diseases and by over 7 folds in control,Whereas the number of PBMCs,whether from liver dis- eases or from control,was increased by only approximately 3 folds. CONCLUSIONS The decreased production of IFNγ in liver dis- eases including HCC is mainly due to endogenous defects of lym- phocytes though the defects of stimulating cofactors such as IL-2 may also be involved. 展开更多
关键词 liver disease INTERLEUKIN-2 interferon type
下载PDF
Cloning and Sequence Analysis of Interferon γ-2β Full-length cDNA in Cyprinus carpio L.
14
作者 陈义龙 冯祥汝 +6 位作者 赵晓 王文东 张俊辉 杨振国 孙真 贾生美 卢强 《Agricultural Science & Technology》 CAS 2012年第6期1230-1233,共4页
[Objective] The research aimed to carry out the cloning, identification and sequence analysis of full-length cDNA of carp interferon γ-2β (IFNγ-2β). [Method] The cDNA library of peripheral blood leucocytes which... [Objective] The research aimed to carry out the cloning, identification and sequence analysis of full-length cDNA of carp interferon γ-2β (IFNγ-2β). [Method] The cDNA library of peripheral blood leucocytes which were separated from carp and stimulated with mitogen was screened by a probe labeled with DIG. The IFNγ- 2β EST sequence was picked out from the constructed cDNA library of peripheral blood leucocyte, and the full length of carp interferon γ-2β was cloned. In addition, the sequence analysis was carried out. [Result] Three positive clones were obtained. Sequence analysis indicated that the sequence had a 119 bp 5’-UTR and a 218 bp 3’-UTR, and the open reading frame (ORF)of this gene was 537 bp which putatively coded 178 amino acids and there were several instable motifs for mRNA (ATTTA) in the 3’-untranslated region. Its homology with IFN from GenBank was up to 97% . Analysis on protein sequence and structure showed that the predicted protein sequence was identified as an IFN family signature. [Conclusion] The research laid the foundation for further studying the expression manner, function characteristic and regulation mechanism of IFNγ-2β in vivo and the action mechanism in the inflammatory reaction, emergency reaction and immune response. 展开更多
关键词 Common carp interferon gamma-2β CLONING Sequencing analysis
下载PDF
Context-dependent role of sirtuin 2 in inflammation
15
作者 NoemíSola-Sevilla Maider Garmendia-Berges +1 位作者 MCarmen Mera-Delgado Elena Puerta 《Neural Regeneration Research》 SCIE CAS 2025年第3期682-694,共13页
Sirtuin 2 is a member of the sirtuin family nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, known for its regulatory role in different processes, including inflammation. In this context, sirtuin 2 has... Sirtuin 2 is a member of the sirtuin family nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, known for its regulatory role in different processes, including inflammation. In this context, sirtuin 2 has been involved in the modulation of key inflammatory signaling pathways and transcription factors by deacetylating specific targets, such as nuclear factor κB and nucleotide-binding oligomerization domain-leucine-rich-repeat and pyrin domain-containing protein 3(NLRP3). However, whether sirtuin 2-mediated pathways induce a pro-or an anti-inflammatory response remains controversial. Sirtuin 2 has been implicated in promoting inflammation in conditions such as asthma and neurodegenerative diseases, suggesting that its inhibition in these conditions could be a potential therapeutic strategy. Conversely, arthritis and type 2 diabetes mellitus studies suggest that sirtuin 2 is essential at the peripheral level and, thus, its inhibition in these pathologies would not be recommended. Overall, the precise role of sirtuin 2 in inflammation appears to be context-dependent, and further investigation is needed to determine the specific molecular mechanisms and downstream targets through which sirtuin 2 influences inflammatory processes in various tissues and pathological conditions. The present review explores the involvement of sirtuin 2 in the inflammation associated with different pathologies to elucidate whether its pharmacological modulation could serve as an effective strategy for treating this prevalent symptom across various diseases. 展开更多
关键词 interferon INFLAMMATION LIPOPOLYSACCHARIDE NEUROINFLAMMATION NLRP3 nuclear factorκB sirtuin 2
下载PDF
支气管哮喘患儿血清MMP-9、INF-γ水平对治疗后气道重塑的预测价值
16
作者 周令 李红叶 +3 位作者 张雷 陈海燕 黄思慧 储卫红 《郑州大学学报(医学版)》 北大核心 2025年第1期122-125,共4页
目的:分析支气管哮喘患儿血清基质金属蛋白酶-9(MMP-9)、干扰素-γ(IFN-γ)水平对治疗后气道重塑的预测价值。方法:选择驻马店市中心医院2018年10月至2022年5月收治的217例支气管哮喘患儿作为研究对象,均于治疗前检测肺功能[第1秒用力... 目的:分析支气管哮喘患儿血清基质金属蛋白酶-9(MMP-9)、干扰素-γ(IFN-γ)水平对治疗后气道重塑的预测价值。方法:选择驻马店市中心医院2018年10月至2022年5月收治的217例支气管哮喘患儿作为研究对象,均于治疗前检测肺功能[第1秒用力呼气容积占用力肺活量的百分比(FEV1/FVC)、呼气峰值流速(PEF)]、血清MMP-9及IFN-γ水平,分析血清MMP-9、IFN-γ水平对治疗后气道重塑的预测价值。结果:治疗2周后发生气道重塑36例。气道重塑患儿治疗前FEV1/FVC、PEF及血清IFN-γ水平均低于未发生气道重塑患儿,血清MMP-9水平高于未发生气道重塑患儿(P<0.05)。血清MMP-9水平较高[OR(95%CI)为1.077(1.046~1.109)]及IFN-γ水平较低[OR(95%CI)为0.894(0.851~0.938)]的患儿治疗后发生气道重塑的风险较高。患儿治疗前血清MMP-9、IFN-γ水平及二者联合预测治疗后气道重塑的AUC(95%CI)分别为0.843(0.773~0.911)、0.813(0.746~0.880)、0.982(0.968~0.996),敏感度为0.833、0.834、0.901,特异度为0.840、0.833、0.972。结论:血清MMP-9水平较高及IFN-γ水平较低可增加支气管哮喘患儿治疗后气道重塑风险,二者及二者联合对气道重塑均有较高预测价值。 展开更多
关键词 支气管哮喘 气道重塑 基质金属蛋白酶-9 干扰素-Γ
下载PDF
Effects of γ interferon on hepatic fibrosis of schistosoma japonicum infected mice *
17
作者 贺永文 刘薇 +1 位作者 曾令兰 罗端德 《World Journal of Gastroenterology》 SCIE CAS CSCD 1997年第1期18+9-11,9-11,共4页
AIM To probe the effect of γ IFN on hepatic fibrosis in schistosomiasis japonica.
关键词 Schistosomiasis Liver cirrhosis interferon type Granuloma Extracellular matrix
下载PDF
慢性乙型肝炎临床治愈的研究现状与前景
18
作者 彭语晨 邬小萍 《西南医科大学学报》 2025年第1期27-31,共5页
慢性乙型肝炎是一种进展性疾病,每年导致大量患者因肝硬化和肝细胞癌死亡。近年来,随着对乙型肝炎病毒感染机制的深入研究,对于核苷(酸)类似物和长效干扰素不同转化策略的研究以及新药开发的进展,乙型肝炎治愈成为可实现的目标。本文就... 慢性乙型肝炎是一种进展性疾病,每年导致大量患者因肝硬化和肝细胞癌死亡。近年来,随着对乙型肝炎病毒感染机制的深入研究,对于核苷(酸)类似物和长效干扰素不同转化策略的研究以及新药开发的进展,乙型肝炎治愈成为可实现的目标。本文就乙型肝炎临床治愈的概念、历史发展、可能的机制、治疗现状,以及新药研发的最新进展作一述评。探讨在治愈过程中面临的挑战以及未来努力的方向,以供临床参考与借鉴。 展开更多
关键词 慢性乙型肝炎 临床治愈 治疗策略 核苷(酸)类似物 干扰素
下载PDF
cGAS-STING通路在肿瘤免疫治疗中的作用机制与研究进展
19
作者 王适豪 石万瑞 +1 位作者 刘轶 张皓 《高等学校化学学报》 北大核心 2025年第1期66-75,共10页
环磷酸鸟苷酸合成酶[Cyclic guanosine monophosphate-adenosine monophosphate(GMP-AMP)synthase,cGAS蛋白]-干扰素刺激因子(Stimulator of interferon genes,STING蛋白)(cGAS-STING)信号通路是识别细胞质中异常DNA、激活先天免疫应答... 环磷酸鸟苷酸合成酶[Cyclic guanosine monophosphate-adenosine monophosphate(GMP-AMP)synthase,cGAS蛋白]-干扰素刺激因子(Stimulator of interferon genes,STING蛋白)(cGAS-STING)信号通路是识别细胞质中异常DNA、激活先天免疫应答系统的重要通路.cGAS蛋白在识别细胞质内异常DNA后,可催化三磷酸腺苷(ATP)和三磷酸鸟苷(GTP)合成环状鸟苷酸二磷酸腺苷(Cyclic GMP-AMP,cGAMP).cGAMP作为第二信使激活STING蛋白,促进I型干扰素的释放,从而引起一系列免疫反应.cGAS-STING通路可以调控肿瘤的转移和增长,参与抗肿瘤的先天免疫反应,探究cGAS-STING通路的作用机制在肿瘤免疫治疗中具有重要意义.本综合评述介绍了cGAS-STING通路的作用机制,概述了目前在抗肿瘤免疫治疗中激活cGAS-STING通路的各类策略. 展开更多
关键词 环磷酸鸟苷酸合成酶-干扰素刺激因子信号通路 肿瘤 免疫治疗 纳米药物
下载PDF
Acute Toxicity of Recombinant Porcine Interferon-alpha
20
作者 王兴满 赵俊 +6 位作者 李京培 刘伯玉 汤仁树 俞海洋 胡勇 王燕来 王明丽 《Animal Husbandry and Feed Science》 CAS 2009年第4期38-40,46,共4页
To observe the acute toxicity of recombinant porcine interferen-alpha (IFN-alpha) in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were d... To observe the acute toxicity of recombinant porcine interferen-alpha (IFN-alpha) in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were divided into two major groups (intraperitoneally injected group and intramuscularly injected group) respectively at high dose, moderate dose and low dose. And the normal control group was also set up. Within 14 d after administration, the behavior of mouse and the degree of toxicity were continuously observed. The hematological indexes and biochemical indexes of blood were detected to obtain the preliminary toxicity data of the recombinant porcine IFN-alpha. And at the end of the experiment, mice were sacrificed for autopsy. [ Result] There was not significant difference in external performance, behavioral characteristics, body temperature, weight, pathological anatomy of visceral organs, hematological indexes and biochemical indexes between the experimental groups and the control group. [ Conclusion] The highest dose of porcine interferon (5.0 x 10s IU per mouse) in this experiment or the dose lower than this dosage should not have significant toxic effects on mice, and the recombinant porcine IFN-alpha is safe in clinical application. 展开更多
关键词 Recombinant porcine interferon-alpha Acute toxicity MICE
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部